Synthetic Biology Market

Synthetic Biology Market (Product Type: Core Products, Enabling Products, DNA Synthesis, and Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Synthetic Biology Market Outlook 2031

  • The global market was valued at US$ 10.7 Bn in 2021
  • The global market is projected to advance at a CAGR of 21.3% from 2022 to 2031
  • The global market is anticipated to reach more than US$ 74.7 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

The synthetic biology market is growing at a rapid pace owing to the increase in demand for renewable fuel and bio-based chemicals; and inexpensive drugs and vaccines, which utilize synthetic biology techniques and products.

Additionally, participation of various organizations, such as BioBricks, DIYbio, and SynBERC, in the development of synthetic biology is expected to augment the global market during the forecast period.

Rise in advancements in synthetic biology and increase in demand for genetically modified crops due to surging population are also driving the global market. Companies operating in the market are focusing on innovation in the field of synthetic biology, such as cell free synthetic biology, to enhance their revenue streams.

Synthetic Biology Market

Synthetic Biology Market Introduction

Synthetic biology is a branch of science that deals with the re-engineering of organisms for useful purpose by transforming them into new possibilities. Synthetic biologists and key players across the world are harnessing the power of nature to solve problems in medicine, manufacturing, and agriculture.

Synthetic biology projects often aim to redesign organisms to make a substance, such as a drug or fuel, or acquire a new ability such as sensing something in the environment. Microorganisms used for bioremediation, rice modified to produce beta-carotene, and yeast modified to produce rose oil are some examples of synthetic biology.

Molecular genetics has become an integral part of biomedical science and clinical practice, having major implications in deciphering the pathogenesis and progression of disease, identifying diagnostic markers & prognosis, and designing better targeted treatments. Synthetic biology in medicine plays an important role in the Request a sample to get extensive insights into the Synthetic Biology Market

Rise in Demand for Improved Drugs and Vaccines to Drive Global Market for Synthetic Biology

Synthetic biology is one of the solutions to reduce the risk of antibiotic-resistant microorganisms, which is a significant threat to drug development organizations. Manufacturers are applying synthetic biology to drug and vaccine development, as it is a process in which man-made biological materials are produced using biological devices and systems.

Synthetic biology is a process widely accepted by companies for the production of innovative and personalized drugs (drugs and vaccines). In 2014, the Massachusetts Institute of Technology (MIT) partnered with Pfizer to develop personalized and innovative drugs. Rise in prevalence of infectious diseases is driving the global market share of synthetic biology .

Infectious diseases such as H1N1, H1N5, and dengue fever are rampant among the population, and individualized and innovative treatments (drugs or vaccines) are needed to overcome them. Therefore, pharmaceutical companies have changed/adopted synthetic biology processes to recognize and improve the treatment of a particular disease/disorder. The global market trends indicate significant growth related to treatment enhancement.

Advancement in Molecular Biology to Boost Demand for Synthetic Biology

Synthetic biology uses gene synthesis and DNA sequencing at a basic level to perform advanced experiments. Rapid progress has been made in the field of molecular biotechnology such as FISH, PCR, and aCGH. Advent of these innovative technologies enables experts to detect genetic anomalies and hidden chromosomal aberrations at an early stage of a disease. The FISH technique detects changes in chromosome number and structure.

PCR is a revolutionary sequencing method that can generate millions of DNA in a short time. The results obtained from this technique help doctors to decide what type of treatment is needed for a patient and monitor him or her during treatment selection. Array CGH is another molecular biology technique, which is widely used for clinical research in constitutional cytogenetics, rare diseases, cancer, and reproductive health.

aCGH provides high-resolution, genome-wide analysis for the detection of chromosome-wide aneuploidies, microsatellite deletions, and single exon-resolution duplication and replication neutral events such as loss of heterozygosity (LoH) and uniparental disomy (UPD). Rapid advancements in molecular biology enable researchers to find an effective result within a short time. Thus, advancement in molecular biology is driving the global market size of synthetic biology.

Request a custom report on Synthetic Biology Market

Superior Benefits and Satisfaction Fueling Core Products Segment

In terms of product type, the global market has been bifurcated into core products and enabling products. The core products segment has been classified into synthetic DNA, synthetic genes, synthetic cells, synthetic clones XNA & chassis organisms, and others.

The synthetic DNA sub-segment dominated the core products segment in 2021. Core products include a range of products that provide superior consumer benefits and satisfaction. These are tools designed primarily for high level synthesis products.

Synthetic DNA can bring out the functions of cells by artificially building them into existing DNA. These DNAs are injected directly into the cell nucleus to build a synthetic organism with the desired functionality. Synthetic genes are generated artificially for the development of economic genes that satisfy specific needs of consumers. These genes are produced in laboratories or clinics using artificial gene synthesis to modify the sequences of genes.

Advancement in synthetic biology and introduction of advanced technologies in the field of genetic, biology, engineering and computer sciences are augmenting the synthetic DNA sub-segment.

Usage in Modification of Genetic Foods, Gene Cloning, and Gene Therapy Propelling Genome Engineering Segment

Based on technology, the global market has been classified into genome engineering, DNA sequencing, bioinformatics, biological components & integrated systems, microfluides, nanotechnology, and others. The genome engineering segment held major share of the global market in 2021. Genome engineering can be used to modify genetic foods, gene cloning, and gene therapy. Furthermore, the technique could be used in defeating various diseases.

Production of Drugs and Vaccines at Lower Cost Bolstering Healthcare Segment

Based on application, the global market has been divided into healthcare, chemicals, agriculture, and others. The healthcare segment accounted for the largest share of the global market in 2021.

This can be ascribed to the increase in utilization of synthetic biology technique to produce drugs and vaccines at lower cost. furthermore, the commercial availability of synthetic DNA and synthetic genes is driving the healthcare segment.

Regional Analysis of Global Synthetic Biology Market

According to the market research analysis, Europe accounted for major share of the global market in 2021. This can be ascribed to consistent efforts by the European Union (EU) toward the development of synthetic biology in the region. Increase in application of synthetic biology techniques in the field of energy, health, environment, and other areas is driving the market in Europe.

The European Commission has provided funding for an initiative on New and Emerging Technologies (NEST) within the 6th Framework Programme (FP6). This initial funding was intended to encourage synthetic biology research in Europe that later would be supported by local funding agencies.

Additional investment came as part of the Horizon 2020 Programme, which ran from 2014 to 2020, offering a total of 21 grants focused on synthetic biology. Thus, rigorous efforts of these organizations is likely to provide a strong platform for the development of synthetic biology in Europe.

North America held the second-largest share of the global market in 2021. Increase in scientific research and novel technologies that could expand the scope for the development of synthetic biology is propelling the market in the region. Synthetic biology is rapidly growing in scientific and innovative sectors owing to its potential impact on health, environment, security, and human rights.

Analysis of Key Players in Global Synthetic Biology Market

The global market is consolidated, with presence of a small number of large companies. Majority of the companies are investing significantly in research and development activities, primarily to introduce environmentally-friendly products. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by major players.

Leading players in the global synthetic biology market are Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.

Key Developments in Global Synthetic Biology Market

  • On September 6, 2022, Synlogic, Inc. collaborated with Roche for the development of novel synthetic biotic to treat inflammatory bowel disease
  • In August 2022, A-Alpha Bio announced a collaboration with Bristol-Myers Squibb to discover molecular glue targets for protein degradation
  • On April 5, 2022, Twist Bioscience Corporation announced a new supply agreement with Ginkgo Bioworks for expanding the depth and breadth of the collaboration in the synthetic biology ecosystem
  • In August 2021, Codex DNA, one of the pioneers of the automated benchtop synthetic biology systems, announced a collaboration with researchers from the U.S. Department of Agriculture’s Research Service to identify the scalable therapeutic measures against citrus greening disease

Each of these players has been profiled in market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Market Snapshot of Synthetic Biology

Attribute

Detail

Market Size Value in 2021

US$ 10.7 Bn

Market Forecast Value in 2031

More than US$ 74.7 Bn

Growth Rate

(CAGR)

21.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Core Products
      • Synthetic DNA
      • Synthetic Genes
      • Synthetic Cells
      • XNA & Chassis Organisms
      • Others
    • Enabling Products
      • DNA Synthesis
      • Oligonucleotide Synthesis
  • Technology
    • Genome Engineering
    • DNA Sequencing
    • Bioinformatics
    • Biological Components & Integrated Systems
    • Nanotechnology
    • Others
  • Application
    • Healthcare
    • Chemicals
    • Agriculture
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Bristol-Myers Squibb
  • Gevo, Inc.
  • Life Technologies
  • DSM
  • DuPont, Inc.
  • Genomatica, Inc.
  • LS9 Inc.
  • Amyris, Inc.
  • Codexis, Inc.
  • Twist Bioscience
  • Ginkgo Bioworks
  • GenScript
  • Insitro
  • ElevateBio
  • Precigen, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global synthetic biology market in 2021?

The global synthetic biology market was valued at US$ 10.7 Bn in 2021

How big will be the global synthetic biology market in 2031?

The global synthetic biology market is projected to reach more than US$ 74.7 Bn by 2031

What was the CAGR of the global synthetic biology market from 2017 to 2021?

The global synthetic biology market advanced at a CAGR of 21.7% from 2017 to 2021

What will be the CAGR of the global synthetic biology market during the forecast period (2022–2031)?

The global synthetic biology market is anticipated to advance at a CAGR of 21.3% from 2022 to 2031

What are the prominent trends that affect market growth?

Rise in demand for improved drugs & vaccines and advancement in molecular biology

Which region is likely to account for the major market share during the forecast period?

Europe is expected to account for the largest share of the global market during the forecast period

Who are the prominent players in the global synthetic biology market?

Bristol-Myers Squibb, Gevo, Inc., Life Technologies, DSM, DuPont, Inc., Genomatica, Inc., LS9, Inc., Amyris, Inc., Codexis, Inc., Twist Bioscience, Ginkgo Bioworks, GenScript, Insitro, ElevateBio, and Precigen, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Synthetic Biology Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Synthetic Biology Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key industry events (mergers & acquisitions, product launch, partnerships, etc.)

        5.2. Technological advancements

        5.3. Government funding & funding deals

        5.4. Covid-19 Pandemic impact on the Industry

    6. Global Synthetic Biology Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Core Products

                6.3.1.1. Synthetic DNA

                6.3.1.2. Synthetic Genes

                6.3.1.3. Synthetic Clones

                6.3.1.4. Synthetic Cells

                6.3.1.5. XNA & Chassis Organisms

                6.3.1.6. Others

            6.3.2. Enabling Products

                6.3.2.1. DNA Synthesis

                6.3.2.2. Oligonucleotide Synthesis

        6.4. Market Attractiveness Analysis, by Product

    7. Global Synthetic Biology Market Analysis and Forecast, by Technology

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Genome Engineering

            7.3.2. DNA Sequencing

            7.3.3. Bioinformatics

            7.3.4. Biological Components & Integrated Systems

            7.3.5. Nanotechnology

            7.3.6. Others

        7.4. Market Attractiveness Analysis, by Technology

    8. Global Synthetic Biology Market Analysis and Forecast, by Application

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Application, 2017–2031

            8.3.1. Healthcare

            8.3.2. Chemicals

            8.3.3. Agriculture

            8.3.4. Others

        8.4. Market Attractiveness Analysis, by Application

    9. Global Synthetic Biology Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Synthetic Biology Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product, 2017–2031

            10.2.1. Core Products

                10.2.1.1. Synthetic DNA

                10.2.1.2. Synthetic Genes

                10.2.1.3. Synthetic Clones

                10.2.1.4. Synthetic Cells

                10.2.1.5. XNA & Chassis Organisms

                10.2.1.6. Others

            10.2.2. Enabling Products

                10.2.2.1. DNA Synthesis

                10.2.2.2. Oligonucleotide Synthesis

        10.3. Market Value Forecast, by Technology, 2017–2031

            10.3.1. Genome Engineering

            10.3.2. DNA Sequencing

            10.3.3. Bioinformatics

            10.3.4. Biological Components & Integrated Systems

            10.3.5. Nanotechnology

            10.3.6. Others

        10.4. Market Value Forecast, by Application, 2017–2031

            10.4.1. Healthcare

            10.4.2. Chemicals

            10.4.3. Agriculture

            10.4.4. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product

            10.6.2. By Technology

            10.6.3. By Application

            10.6.4. By Country

    11. Europe Synthetic Biology Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product, 2017–2031

            11.2.1. Core Products

                11.2.1.1. Synthetic DNA

                11.2.1.2. Synthetic Genes

                11.2.1.3. Synthetic Clones

                11.2.1.4. Synthetic Cells

                11.2.1.5. XNA & Chassis Organisms

                11.2.1.6. Others

            11.2.2. Enabling Products

                11.2.2.1. DNA Synthesis

                11.2.2.2. Oligonucleotide Synthesis

        11.3. Market Value Forecast, by Technology, 2017–2031

            11.3.1. Genome Engineering

            11.3.2. DNA Synthesis

            11.3.3. Bioinformatics

            11.3.4. Biological Components & Integrated Systems

            11.3.5. Nanotechnology

            11.3.6. Others

        11.4. Market Value Forecast, by Application, 2017–2031

            11.4.1. Healthcare

            11.4.2. Chemicals

            11.4.3. Agriculture

            11.4.4. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product

            11.6.2. By Technology

            11.6.3. By Application

            11.6.4. By Country/Sub-region

    12. Asia Pacific Synthetic Biology Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product, 2017–2031

            12.2.1. Core Products

                12.2.1.1. Synthetic DNA

                12.2.1.2. Synthetic Genes

                12.2.1.3. Synthetic Clones

                12.2.1.4. Synthetic Cells

                12.2.1.5. XNA & Chassis Organisms

                12.2.1.6. Others

            12.2.2. Enabling Products

                12.2.2.1. DNA Synthesis

                12.2.2.2. Oligonucleotide Synthesis

        12.3. Market Value Forecast, by Technology, 2017–2031

            12.3.1. Genome Engineering

            12.3.2. DNA Sequencing

            12.3.3. Bioinformatics

            12.3.4. Biological Components & Integrated Systems

            12.3.5. Nanotechnology

            12.3.6. Others

        12.4. Market Value Forecast, by Application, 2017–2031

            12.4.1. Healthcare

            12.4.2. Chemicals

            12.4.3. Agriculture

            12.4.4. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product

            12.6.2. By Technology

            12.6.3. By Application

            12.6.4. By Country/Sub-region

    13. Latin America Synthetic Biology Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product, 2017–2031

            13.2.1. Core Products

                13.2.1.1. Synthetic DNA

                13.2.1.2. Synthetic Genes

                13.2.1.3. Synthetic Clones

                13.2.1.4. Synthetic Cells

                13.2.1.5. XNA & Chassis Organisms

                13.2.1.6. Others

            13.2.2. Enabling Products

                13.2.2.1. DNA Synthesis

                13.2.2.2. Oligonucleotide Synthesis

        13.3. Market Value Forecast, by Technology, 2017–2031

            13.3.1. Genome Engineering

            13.3.2. DNA Sequencing

            13.3.3. Bioinformatics

            13.3.4. Biological Components & Integrated Systems

            13.3.5. Nanotechnology

            13.3.6. Others

        13.4. Market Value Forecast, by Application, 2017–2031

            13.4.1. Healthcare

            13.4.2. Chemicals

            13.4.3. Agriculture

            13.4.4. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product

            13.6.2. By Technology

            13.6.3. By Application

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Synthetic Biology Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product, 2017–2031

            14.2.1. Core Products

                14.2.1.1. Synthetic DNA

                14.2.1.2. Synthetic Genes

                14.2.1.3. Synthetic Clones

                14.2.1.4. Synthetic Cells

                14.2.1.5. XNA & Chassis Organisms

                14.2.1.6. Others

            14.2.2. Enabling Products

                14.2.2.1. DNA Synthesis

                14.2.2.2. Oligonucleotide Synthesis

        14.3. Market Value Forecast, by Technology, 2017–2031

            14.3.1. Genome Engineering

            14.3.2. DNA Synthesis

            14.3.3. Bioinformatics

            14.3.4. Biological Components & Integrated Systems

            14.3.5. Nanotechnology

            14.3.6. Others

        14.4. Market Value Forecast, by Application, 2017–2031

            14.4.1. Healthcare

            14.4.2. Chemicals

            14.4.3. Agriculture

            14.4.4. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product

            14.6.2. By Technology

            14.6.3. By Application

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player – Competition Matrix (by tier and size of companies)

        15.2. Market Share/Ranking Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. Bristol-Myers Squibb

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Strategic Overview

            15.3.2. Gevo, Inc.

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Strategic Overview

            15.3.3. Life Technologies

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Strategic Overview

            15.3.4. DSM

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Strategic Overview

            15.3.5. DuPont, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Strategic Overview

            15.3.6. Genomatica, Inc.

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Strategic Overview

            15.3.7. LS9, Inc.

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Strategic Overview

            15.3.8. Amyris, Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Strategic Overview

            15.3.9. Codexis, Inc.

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Strategic Overview

            15.3.10. Twist Bioscience

                15.3.10.1. Company Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Strategic Overview

            15.3.11. Ginkgo Bioworks

                15.3.11.1. Company Overview

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Strategic Overview

            15.3.12. GenScript

                15.3.12.1. Company Overview

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Strategic Overview

            15.3.13. Insitro

                15.3.13.1. Company Overview

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Strategic Overview

            15.3.14. ElevateBio

                15.3.14.1. Company Overview

                15.3.14.2. Product Portfolio

                15.3.14.3. SWOT Analysis

                15.3.14.4. Strategic Overview

            15.3.15. Precigen, Inc.

                15.3.15.1. Company Overview

                15.3.15.2. Product Portfolio

                15.3.15.3. SWOT Analysis

                15.3.15.4. Strategic Overview

    List of Tables

    Table 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 02: Synthetic Biology Market Value (US$ Mn) Forecast, by 2017‒2031, by Technology

    Table 03: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 04: Global Synthetic Biology Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 07: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

    Table 08: North America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 09: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

    Table 10: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 11: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

    Table 12: Europe Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 13: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 15: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

    Table 16: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 18: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 19: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

    Table 20: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 21: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 22: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Product, 2017‒2031

    Table 23: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Technology, 2017‒2031

    Table 24: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, by Application, 2017–2031

    List of Figures

    Figure 01: Global Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Synthetic Biology Market Value Share, by Product, 2021

    Figure 03: Global Synthetic Biology Market Value Share, by Technology, 2021

    Figure 04: Global Synthetic Biology Market Value Share, by Application, 2021

    Figure 05: Global Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 06: Global Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 07: Global Synthetic Biology Market Value (US$ Mn), by Core Products, 2017‒2031

    Figure 08: Global Synthetic Biology Market Value (US$ Mn), by Enabling Products, 2017‒2031

    Figure 09: Global Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 10: Global Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 11: Global Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 12: Global Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 13: Global Synthetic Biology Market Value Share Analysis, by Region, 2021 and 2031

    Figure 14: Global Synthetic Biology Market Attractiveness Analysis, by Region, 2022–2031

    Figure 15: North America Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 16: North America Synthetic Biology Market Value Share Analysis, by Country, 2021 and 2031

    Figure 17: North America Synthetic Biology Market Attractiveness Analysis, by Country, 2022–2031 

    Figure 18: North America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 19: North America Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 20: North America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 21: North America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 22: North America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 23: North America Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 24: Europe Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 25: Europe Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 26: Europe Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 27: Europe Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 28: Europe Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 29: Europe Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 30: Europe Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 31: Europe Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 32: Europe Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 33: Asia Pacific Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 34: Asia Pacific Synthetic Biology Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 35: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 36: Asia Pacific Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 37: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 38: Asia Pacific Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 39: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 40: Asia Pacific Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 41: Asia Pacific Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 42: Latin America Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 43: Latin America Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

    Figure 44: Latin America Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

    Figure 45: Latin America Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 46: Latin America Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 47: Latin America Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 48: Latin America Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 49: Latin America Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 50: Latin America Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 51: Middle East & Africa Synthetic Biology Market Value (US$ Mn) Forecast, 2017–2031

    Figure 52: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Country/Sub-Region, 2021 and 2031

    Figure 53: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Country/Sub-Region, 2021-2031

    Figure 54: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Product, 2021 and 2031

    Figure 55: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Product, 2022–2031

    Figure 56: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Technology, 2021 and 2031

    Figure 57: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 58: Middle East & Africa Synthetic Biology Market Value Share Analysis, by Application, 2021 and 2031

    Figure 59: Middle East & Africa Synthetic Biology Market Attractiveness Analysis, by Application, 2022–2031

    Figure 60: Company Share Analysis, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved